Methods of using ryanodine antagonists in treating neural injury
AssigneeAllergan, Inc.
InventorsCun-Jian Dong, William A. Hare
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a ryanodine antagonist, e.g. dantrolene, to inhibit or prevent nerve cell injury or death.
Claims16
A method of providing neural protection in acute and chronic neural disorders in human patients comprising administering to said patients suffering from said disorders an effective amount of a compound that is a ryanodine receptor antagonist in pharmaceutically acceptable vehicle to inhibit or prevent nerve cell injury or death.
Dependencies are inferred from the claim text.